← Open Payments lookup

TANYA LEWIS: Open Payments

NPI 1831304583 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,218 in 71 payments from 15 companies in 2025. Trend: 2023 $1,049 · 2024 $1,038 · 2025 $1,218

Food & beverage: $1,218
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.17$274
Otsuka America Pharmaceutical, Inc.10$183
Alkermes, Inc.8$144
Janssen Pharmaceuticals, Inc7$126
Teva Pharmaceuticals USA, Inc.7$117
Luye Pharma (USA) Ltd.4$77
Supernus Pharmaceuticals, Inc.5$77
E.R. Squibb & Sons, L.L.C.3$73
Lundbeck LLC2$39
Almatica Pharma LLC2$31

Products named: INGREZZA, REXULTI, ARISTADA, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, Qelbree, UZEDY, COBENFY.

Industry payments across NY — which companies pay providers there.